NonExomics, Inc is a scientists-led company that has pioneered the discovery process of the new wave of targets from the so-called Dark Genome. Over the last 8 years, we have meticulously developed AI-based algorithms deployed on the patient data at a population scale, to discover over 250,000 new proteins and investigated their disruptions in over 1365 human diseases. We have performed extensive in silico and experimental validation on these new targets to develop them as diagnostics and therapeutics.
Our target portfolio serves as a parallel universe in drug discovery that is ripe to be challenged by the available therapeutic modalities in various diseases.
We welcome opportunities to collaborate with other partners in challenging these newly-found genes using small molecules, antisense oligos, antibodies, gene therapy, etc.
Company Details
- Employees
- 7
- Address
- North Shore Innoventures, 100 Cummings Center, Suite 451c, Beverly,massachusetts 01915,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.nonexomics.com
- Keywords
- Dark Genome, Novel Proteins, Undiscovered Proteins, Artificial Intelligence (AI), Biotechnology, Structural Biology, Genomics, Redefining Genome, NonExomics, New Biomarkers, New Target - Drug discovery.
- HQ
- Beverly, Massachusetts
Nonexomics Questions
Nonexomics's website is http://www.nonexomics.com
Nonexomics's LinkedIn profile is https://www.linkedin.com/company/nonexomics
Nonexomics has
7 employees.
View email and phone details for 7
employees at Nonexomics.
Nonexomics's industry is
Biotechnology Research
Nonexomics's top competitors are
Hc Bioscience, Inc.,
Bbsrc,
Quinn,
Uk Research And Innovation,
Dromics Research Lab,
Bluebird Bio,
Formation Venture Engineering,
Orna Therapeutics,
Source Bioscience,
Rethink Bio.
Nonexomics's categories are Biotechnology Research
